Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM 85 to Prevent Respiratory Infections in Older At Risk Patients
NCT07178002Phase 4Active, not recruiting
- Sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico
- Start
- Dec 2024
- Primary completion
- Jan 2026
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of OM-85 in respiratory tract infection (RTI), sponsored by Fondazione Policlinico Universitario Campus Bio-Medico. Started Dec 2024; status: active, not recruiting.
02
Drugs
OM-85
03
Conditions
respiratory tract infection (RTI)
Beyond the preview
Go deeper on NCT07178002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07178002.